Denmark’s Pharmacosmos to buy G1 Therapeutics for $405 million
Danish biotechnology company, Pharmacosmos A/S will buy US-based G1 Therapeutics Inc., for $405 million to expand its global commercial portfolio in haematology.
Drugs
Health
Pharma
Drugs
Health
Pharma
WHO: 40 athletes participating in Olympic Games test Covid-19 positive
The WHO’s event-based surveillance system has reported that at least 40 athletes participating in the Olympic Games in France had tested positive for
Drugs
Health
Pharma
Scientists inject goo in sheep’s knee joints to regenerate cartilage
Scientists at Northwestern University's Simpson Querrey Institute for BioNanotechnology have invented a bioactive material to successfully regenerate cartilage in the knee joints of
Drugs
Health
Pharma
France’s Servier gets FDA green light for oral drug to treat brain cancer
Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat
Drugs
Health
Pharma
Daiichi Sankyo to pay Merck $170 million for cancer test drug rights
Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for
Drugs
Health
Pharma
Scientists develop potential compound to neutralise flesh-eating bacteria
A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested
Drugs
Health
Pharma
New cardiovascular risk calculator may impose a burden on 16 million US citizens
HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the
Drugs
Health
Pharma
Contineum’s test drug may reverse multiple sclerosis damage
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs
Medical
Pharma
Oxford spin-off develops new test to detect heart attacks 10 yrs in advance
Caristo Diagnostics, founded by four Oxford University cardiologists, has developed an AI-assisted software that can detect cardiac events a decade in advance.
Drugs
Medical
Pharma
Artificial blood vessels can improve heart surgery outcomes: UoE
Flexible, gel-like synthetic tubes can replace human veins during heart bypass operations to reroute blood flow, according to engineers at the University of